Nautilus Biotechnology (NASDAQ:NAUT) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.15) by 26.67 percent. This is a 8.33 percent increase over losses of $(0.12) per share from the same period last year.
Nasdaq Down Over 1%; US Retail Sales Top Expectations
U.S. stocks traded lower this morning, with the Nasdaq Composite falling more than 1% on Tuesday.
Following the market opening Tuesday, the Dow traded down 0.11% to 33,947.98 while the NASDAQ fell 1.33% to 13,387.41. The S&P 500 also fell, dropping, 0.70% to 4,343.02.
